Puyol Pallas M, Gómez Parada J
Servicio de Urología, Hospital San Juan de Dios, Martorell, Barcelona.
Actas Urol Esp. 1995 Feb;19(2):118-22.
Nineteen patients seen for AUR secondary to benign prostate hypertrophy and with high surgical risk, were treated with an LH-RH agonist (GOSERELIN). After six months of treatment a 43.28% decrease in the prostate volume was seen, Improvement, i.e., spontaneous miction, was achieved in 46.6% patients, although post-mictional volumes remained high.
19例因良性前列腺增生继发急性尿潴留且手术风险高的患者,接受了促黄体生成素释放激素激动剂(戈舍瑞林)治疗。治疗6个月后,前列腺体积下降了43.28%,46.6%的患者病情得到改善,即实现了自主排尿,尽管排尿后残余尿量仍很高。